86 related articles for article (PubMed ID: 6677980)
1. [Alpha 1-acid glycoprotein and carbamazepine].
Bruguerolle B; Bussière H; Jadot G
Rev Neurol (Paris); 1983; 139(11):679-80. PubMed ID: 6677980
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
[TBL] [Abstract][Full Text] [Related]
3. Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (Hb ASSG) in epileptic patients with long-term antiepileptic therapy.
Niketić V; Ristić S; Saicić ZS; Spasić M; Buzadzić B; Stojković M
Farmaco; 1995 Nov; 50(11):811-3. PubMed ID: 8593178
[TBL] [Abstract][Full Text] [Related]
4. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A
Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
[TBL] [Abstract][Full Text] [Related]
5. Together, phenobarbital and carbamazepine lower the alpha 1-acid glycoprotein concentration in plasma of epileptic patients.
Bruguerolle B; Jadot G; Bussiere H
Clin Chem; 1984 Apr; 30(4):590-1. PubMed ID: 6705218
[No Abstract] [Full Text] [Related]
6. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Irshaid YM; Hamdi AA; Al Homrany M
Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
[TBL] [Abstract][Full Text] [Related]
7. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
Hernández R; Fernández Mde L; Miranda G; Suástegui R
Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
[TBL] [Abstract][Full Text] [Related]
8. PB:PRM ratio in patients with epilepsy treated with primidone.
Cornaggia CM; Altamura AC; Bianchi M; Canger R; Polana P; Pruneri C
Int J Clin Pharmacol Res; 1983; 3(3):185-93. PubMed ID: 6679521
[TBL] [Abstract][Full Text] [Related]
9. [Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
Ermani M; Giaretta D; Pellegrini A; Chemello R; Testa G
Riv Neurol; 1983; 53(2):81-93. PubMed ID: 6879058
[TBL] [Abstract][Full Text] [Related]
10. [The use of phenobarbital and carbamazepine (finlepsin) in children with epilepsy and cerebral spastic palsy with epileptic syndrome].
Gerasimiuk DL; Gusel' VA; Klimenko VA; Korovin AM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(8):25-7. PubMed ID: 2175112
[TBL] [Abstract][Full Text] [Related]
11. Brainstem auditory evoked potentials in epileptics on different anti-epileptic drugs.
Panjwani U; Singh SH; sel Vamurthy W; Gupta HL; Mukhopadhyay S; Thakur L
Indian J Physiol Pharmacol; 1996 Jan; 40(1):29-34. PubMed ID: 8864768
[TBL] [Abstract][Full Text] [Related]
12. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
[TBL] [Abstract][Full Text] [Related]
13. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children.
Aycicek A; Iscan A
Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706
[TBL] [Abstract][Full Text] [Related]
14. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
[TBL] [Abstract][Full Text] [Related]
15. Laser evoked potentials and carbamazepine in epileptic patients.
Galeotti F; Truini A; Iannetti GD; Romaniello A; Biasiotta A; Mascia A; Virtuoso M; Cruccu G
Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072
[TBL] [Abstract][Full Text] [Related]
16. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR
Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
[TBL] [Abstract][Full Text] [Related]
17. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
Yegnanarayan R; Mahesh SD; Sangle S
Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
[TBL] [Abstract][Full Text] [Related]
18. [Anticonvulsive combined therapy (author's transl)].
Deisenhammer E; Sommer R; Nitsche V
Wien Klin Wochenschr; 1980 Jan; 92(1):23-4. PubMed ID: 6769255
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
[TBL] [Abstract][Full Text] [Related]
20. Fracture risk associated with use of antiepileptic drugs.
Vestergaard P; Rejnmark L; Mosekilde L
Epilepsia; 2004 Nov; 45(11):1330-7. PubMed ID: 15509233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
